Product image of Levetiracetam Noridem (Levetiracetam) supplied by GNH India

Levetiracetam Noridem

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Noridem (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Noridem, is an antiepileptic presented as an intravenous solution for injection use. It is employed to control seizure activity in patients with various types of epilepsy. The formulation is manufactured under EU standards and is supplied as a prescription‑only product.

GNH India supplies Levetiracetam Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides reliable sourcing, regulatory documentation, and logistics support to healthcare institutions across global markets.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is used in the management of epileptic disorders, targeting neuronal hyperexcitability.
  • Partial‑onset seizures: reduces frequency and severity of focal seizures.
  • Myoclonic seizures: diminishes occurrence of sudden, brief muscle jerks.
  • Generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This interaction reduces excessive neuronal firing and lowers the likelihood of seizure propagation across cortical networks, providing broad antiepileptic activity without significant effects on ion channels or GABA receptors.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Fatigue: feeling unusually tired or weak.
  • Somnolence: increased sleepiness during the day.
  • Headache: mild to moderate cranial pain.
  • Irritability: mood changes or agitation.
  • Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Stevens‑Johnson syndrome: rare skin blistering disorder.
  • Blood dyscrasias: abnormal blood counts.
  • Suicidal thoughts: emergence of depressive or suicidal ideation.
  • Severe depression: marked mood disturbances.
  • Rash with systemic symptoms: indicative of hypersensitivity.

Precautions & Warnings

  • When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.
  • Renal impairment: dosage adjustment may be required based on renal function.
  • Hepatic impairment: monitor liver enzymes and clinical response.
  • Concomitant CNS depressants: increased sedation may occur.
  • Pregnancy: risk category unknown; discuss potential benefits and risks with the patient.
  • Driving and operating machinery: caution advised due to possible dizziness or drowsiness.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Co‑administration with other antiepileptic drugs that markedly increase sedation (e.g., phenobarbital, benzodiazepines).
  • Use with strong enzyme‑inducing agents that may reduce levetiracetam plasma levels.

Moderate Interactions (Monitor Closely)

  • Alcohol: may enhance central nervous system depression.
  • Fluoroquinolone antibiotics: potential to lower seizure threshold.
  • Immunosuppressants: monitor for altered immune response.

Frequently Asked Questions

Levetiracetam Noridem is an intravenous antiepileptic medication used to treat partial‑onset, myoclonic, and generalized tonic‑clonic seizures in patients with epilepsy. It helps reduce the frequency and severity of seizure episodes by stabilizing neuronal activity.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action dampens excessive neuronal firing and lowers the likelihood of seizure propagation, providing broad seizure control without directly affecting ion channels or GABA receptors.

The prescribed dose of Levetiracetam Noridem is determined by the treating physician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are individualized, and the medication is administered intravenously under medical supervision.

The safety of levetiracetam in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and discuss them with the patient. Breastfeeding decisions should also be made in consultation with a medical professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Levetiracetam offers a favorable safety profile, minimal drug‑enzyme interactions, and rapid intravenous administration, distinguishing it from many older antiepileptics that require extensive monitoring or have significant hepatic metabolism. It is often chosen when a fast‑acting, well‑tolerated option is needed.

Levetiracetam Noridem should be stored at ambient temperature, below 25 °C, in its original container to protect from moisture and light. Do not freeze the solution, and ensure the vial is kept sealed until use.

The product is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional, typically diluted in compatible IV fluids and infused over a period defined by the prescriber, following aseptic technique.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, blood dyscrasias, and emergence of suicidal thoughts or severe depression. Patients should be monitored closely for any signs of these conditions, and treatment should be discontinued if they occur.

Levetiracetam is contraindicated in patients with known hypersensitivity to levetiracetam or any component of the formulation. Caution is also advised for individuals with severe renal impairment who have not undergone appropriate dose adjustment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.